Alan TN Tita
University of Alabama at Birmingham
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alan TN Tita as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:10 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07746271 · Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST TrialThe George Washington University Biostatistics Center · not yet recruiting · Hypertension in Pregnancy, Obstetrical Complications · principal investigator
- N/ANCT01235546 · Study of Effectiveness and Safety of Azithromycin-based Extended-spectrum Prophylaxis to Prevent Post Cesarean InfectionAlan Tita · completed · Endometritis, Wound Infection, Abscess · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- 1/2 GLobal trial Of Bromocriptine for PeriPartum CardioMyopathy (GLOBal PPCM)UG3HL177574 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2026 · $34,560 awarded in 2026Same name and institution; not confirmed by an ID
- Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST TrialU01HD114633 · NICHD · GEORGE WASHINGTON UNIVERSITY · fiscal years 2025 to 2026 · $3,106,769 awarded in 2026Grant number is on one of their registry trials
- Maternal-Fetal Medicine Units (MFMU) NetworkUG1HD027869 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2016 to 2026 · $326,700 awarded in 2026Same name and institution; not confirmed by an ID
- Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child).R01HD112994 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2023 to 2026 · $1,446,877 awarded in 2026Same name and institution; not confirmed by an ID
- UAB Interdisciplinary Research Scholars' Program in Women's HealthK12AR086524 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2025 to 2026 · $206,388 awarded in 2026Same name and institution; not confirmed by an ID
- Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertensionR01HL155127 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2022 to 2025 · $546,481 awarded in 2025Same name and institution; not confirmed by an ID
- Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)R01HL120338 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2021 to 2025 · $2,007,149 awarded in 2025Same name and institution; not confirmed by an ID
- Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy OutcomesR33HD103061 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2022 to 2024 · $169,950 awarded in 2024Same name and institution; not confirmed by an ID
- Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy OutcomesR21HD103061 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2020 to 2021 · $167,846 awarded in 2021Same name and institution; not confirmed by an ID
- Chronic Hypertension and Pregnancy-CHAP Clinical Coordinating CenterU01HL120338 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2014 to 2020 · $3,700,859 awarded in 2020Same name and institution; not confirmed by an ID
- NICHD Materal Fetal Medicine Units NetworkU10HD027869 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2010 to 2015 · $1 awarded in 2015Same name and institution; not confirmed by an ID
- Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) TrialR01HD064729 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · fiscal years 2010 to 2013 · $566,453 awarded in 2013Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data CoordinatingCenterU24HD036801 · NICHD · GEORGE WASHINGTON UNIVERSITY · PI Rebecca Gersnoviez Clifton · fiscal years 2021 to 2026Named on NCT07746271
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:10 UTC. The ranking covers the 200 most relevant of 114 PubMed records, and a shared surname and initials can bring in a namesake. All 114 on PubMed
- Labor Induction versus Expectant Management in Low-Risk Nulliparous Women.N Engl J Med · 2018919 citationsRCR 59.7
- Antenatal Betamethasone for Women at Risk for Late Preterm Delivery.N Engl J Med · 2016553 citationsRCR 28.1
- Treatment for Mild Chronic Hypertension during Pregnancy.N Engl J Med · 2022433 citationsRCR 39.2
- 334 citationsRCR 17.3
- Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.N Engl J Med · 2017311 citationsRCR 16.6
- Adjunctive Azithromycin Prophylaxis for Cesarean Delivery.N Engl J Med · 2016208 citationsRCR 10.9
- 188 citationsRCR 15.3
- A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis.N Engl J Med · 2015117 citationsRCR 6.3
- 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm.Am J Obstet Gynecol · 2012115 citationsRCR 4.9
- 110 citationsRCR 8.1